Detalles de la búsqueda
1.
Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
Am J Obstet Gynecol
; 227(6): 873.e1-873.e12, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096186
2.
Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.
Eur J Contracept Reprod Health Care
; 25(6): 417-426, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33006493
3.
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
J Sex Med
; 10(12): 3069-79, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24034466
4.
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
Eur J Contracept Reprod Health Care
; 18(4): 264-73, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23651474
5.
Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Eur J Contracept Reprod Health Care
; 18(4): 274-83, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23638631
6.
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Eur J Contracept Reprod Health Care
; 16(4): 258-69, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21774563
7.
Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis.
Sci Rep
; 11(1): 20404, 2021 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34650132
8.
Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter® in a majority nulliparous population.
Contraception
; 96(6): 426-431, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844878
9.
Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study.
Int J Womens Health
; 8: 477-487, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27695365
10.
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.
Int J Womens Health
; 6: 711-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25120376
11.
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Int J Gynaecol Obstet
; 125(3): 270-4, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24713413
12.
Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials.
Reprod Sci
; 20(7): 745-54, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23439617
13.
Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.
Contraception
; 87(2): 227-34, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22995539
14.
Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Contraception
; 86(2): 96-101, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240178
15.
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Clin Drug Investig
; 31(8): 573-584, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21721593
16.
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest.
Int J Womens Health
; 3: 127-32, 2011 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21573149
17.
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
Drugs R D
; 11(2): 159-70, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21679006
Resultados
1 -
17
de 17
1
Próxima >
>>